When: Confirmed close below $86.50 with volume >5M

Then: Exit residual entirely, wait for 200 SMA retest

When: Beat with gross margin expansion and FY27 input-cost discipline upgrades

Then: Upgrade to Hold

When: Miss with margin compression and elevated input-cost disclosure

Then: Confirm bear setup, trim toward Sell/40% sizing

REDUCE / UNDERWEIGHT: Trim 10 to 15 percent of position at current levels; hold residual with protective put structure at $87 strike; maintain dividend stream and dry powder for re-entry if 200 SMA gets tested and holds

• Beta: 0.327 — defensive name with low volatility profile
• Dividend yield: 2.35 percent with aristocrat dividend growth pace
• Bollinger squeeze at $90.10 with bands contracting from $94.32 to $93.89 upside and lower band at $89.06 — coiled spring that releases in both directions
• 200 SMA has climbed from $82.43 to $86.82 — untested support represents trend persistence, not fragility
• Q2'26 revenue up 4.9 percent YoY with net income down 6.7 percent YoY
• Gross margin: 61.5 percent in Q2'26, essentially flat with prior periods
• Operating margin: north of 19 percent
• EBITDA margin (TTM): 23.68 percent
• ROA: 15.84 percent
• Free cash flow (TTM): $3.46 billion against $2.04 billion net income — cash conversion over 1.7x
• MACD crossed below zero with deepening histogram; RSI sliding; price below 10 EMA and 50 SMA with no oversold trigger or breakout confirmation
• Goodwill impairment and Hill's Pet Nutrition under pressure are non-cash, already in the stock — do not affect operating cash flow or dividend capacity
• Recommendation: 10 to 15 percent trim (not 30 to 50 percent), protective put around $87 strike expiring post-earnings, hard stop at $84.50 formalized as hedge

→ vs aggressive: Trimming 30 to 50 percent at squeeze compression guarantees missing the resolution in whichever direction it breaks, locks in premature tax events, surrenders the 2.35 percent yield stream, and removes defensive participation if rates surprise dovish, oil collapses, or defensive bid reasserts — not conservative, reactive

→ vs aggressive: The 200 SMA being 'untested' is not a vacuum but a level that has held every single day of the uptrend; absence of test represents trend persistence, not fragility

→ vs aggressive: P&G 8 percent FY27 EPS headwind is not transferable to CL due to different geographic mixes, category exposures, and pricing strategies — lazy peer analogy

→ vs aggressive: 250 bps Treasury yield pickup math is incomplete — ignores CL's price appreciation optionality, dividend growth at aristocrat pace, and correlation with macro events that drive rate moves

→ vs neutral: Pure HOLD with deteriorating MACD, RSI sliding, price below 10 EMA and 50 SMA with no oversold trigger is denial, not patience — patient capital should still do something

TRIM 20-25% at current levels; split proceeds 50/50 between short-duration Treasuries (~5% yield) and cash/near-cash for re-entry

• Trim 20-25% at current levels (more than conservative's 10-15%, less than aggressive's 30-50%)
• Proceeds split: half into short-duration Treasuries at ~5%, half in cash/near-cash
• Re-entry framework: price re-tests 200 SMA at 86.82 and holds with daily close above 87.50 within two sessions, OR breakout above Bollinger upper band at 93.89 on volume confirmation above VWMA
• Stop at 86.00 on residual position (tighter than aggressive's 84.50, above March-April structural zone of 84-85)
• Skip protective puts due to elevated implied vol and compressed ATR of 1.79; structural stop more cost-efficient
• Operating margin still north of 19%, EBITDA margin 23.68% trailing basis, FCF conversion 1.7x
• 200 SMA at 86.82 is structural strength evidence, not fragility; held from 2025 lows through February 2026 high
• Q2'26: revenue up 4.9%, net income down 6.7% - one quarter of FX and input cost noise, not structural breakdown
• Peer read-through suggests 3-4% input cost pressure vs P&G's 8% EPS headwind
• Goodwill declined from 5.6 billion to ~4.6 billion over past year, signaling ongoing Hill's Pet Nutrition segment pressure

→ vs aggressive: Vacuum argument on 200 SMA is 'upside down' - untested support is evidence of sellers never strong enough to challenge it, not fragility

→ vs aggressive: Squeeze argument cuts both ways - coiled spring releases in whichever direction next catalyst pushes; trimming at maximum compression guarantees missing upside leg

→ vs aggressive: 250bp Treasury pickup is 'incomplete' - ignores CL's optionality on defensive rotation flows, dividend growth, and price appreciation; right comparison is total return potential not just current yield

→ vs aggressive: Margin compression is one quarter of FX and input cost noise in a mature defensive franchise, not 'the death of the franchise'

→ vs conservative: Dividend pedigree framing as inaction excuse is denial - 0.327 beta with bearish MACD cross, deepening histogram, RSI sliding, and no oversold trigger is not patient capital, it's avoidance

→ vs conservative: Protective puts at this IV level with compressed ATR are not capital-efficient for a name with only 0.327 beta; structural stop at 86.00 accomplishes same protection cheaper

→ vs conservative: Peer read-through dismissal is 'lazy fundamental work' - P&G and CL share same input cost environment, FX exposure, consumer environment; likely 3-4% pressure, not full 8% headwind

→ vs conservative: Goodwill impairment dismissal is 'too clean' - trajectory from 5.6B to 4.6B over one year signals ongoing Hill's Pet Nutrition segment pressure, not nothing